Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rituximab Maintenance After Autologous Transplantation

This study has been terminated.
(Closed early due to slow patient accrual and sponsor's withdrawal of support.)
Genentech, Inc.
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: April 12, 2010
Last updated: July 27, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2010
  Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)